Global Hemoglobinopathies Treatment Market Growth Prospects and Strategic Opportunities Through 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Is The Hemoglobinopathies Treatment Market Expected To Grow In Terms Of Size?
In recent times, the market size for hemoglobinopathies treatment has experienced robust growth. It is projected to surge from $9.01 billion in 2024 to $9.85 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.3%. The significant growth during the historic period can be traced back to factors such as scientific breakthroughs, advancements in medicine, patient lobbying, awareness of public health, global cooperation, and research consortia.
Expectations are that the market size of hemoglobinopathies treatment will experience significant growth in the coming years, swelling to $13.84 billion by 2029, with a compound annual growth rate (CAGR) of 8.9%. Several factors are set to contribute to this growth during the forecast period, such as a heightened focus on personalized medicine, regulatory backing for rare diseases, the introduction of prenatal screening programs, enabling early detection of hemoglobinopathies during pregnancy through genetic counseling services, and a broadened use of disease-altering therapies. The upcoming trends identified for the forecast period consist of novel drug therapies, cellular therapies, progress in precision therapeutics, and enhanced diagnostic tools.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15583&type=smp
Which Key Factors Are Fueling Growth In The Hemoglobinopathies Treatment Market?
As genetic inheritance gains increasing prominence, it is anticipated to accelerate the expansion of the hemoglobinopathies treatment market. Genetic inheritance represents the process through which attributes from parents are carried over to their children via DNA in sexual and asexual reproduction. More focus towards genetic inheritance is due to the advancements in genetic research and technology, as it helps in better understanding of the role of genetic factors in numerous diseases, including hemoglobinopathies. There is a significant role played by genetic inheritance in the growth of hemoglobinopathies treatment, by providing improved targeted therapies, personalised medicine, drug development, and diagnosis. In March 2023, for instance, data from Gene People, a registered charity in the UK, estimated that one in every 25 children has a genetic issue, and 30,000 infants and children receive new diagnosis each year. Thus, the rise in genetic inheritance is fuelling the growth of the hemoglobinopathies treatment market.
How Is The Hemoglobinopathies Treatment Market Categorized Across Applications And Types?
The hemoglobinopathies treatmentmarket covered in this report is segmented –
1) By Treatment: Stem Cell Therapy; Blood Transfusion
2) By Application: Thalassemia; Sick Cell Anemia
3) By Distribution Channel: Hospital Pharmacy; Online Providers; Drug Stores And Retail Pharmacy
Subsegments:
1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation (Hsct); Gene Therapy For Hemoglobinopathies; Autologous Stem Cell Therapy; Allogeneic Stem Cell Transplantation; Gene Editing Techniques ( Crispr-cas9); Umbilical Cord Blood Stem Cell Therapy; Bone Marrow Transplantation
2) By Blood Transfusion: Regular Blood Transfusion (For Anemia); Exchange Blood Transfusion; Iron Chelation Therapy Post-Transfusion; Red Blood Cell Transfusions; Haploidentical Blood Transfusions; Leukoreduced Blood Transfusion; Emergency Blood Transfusion In Severe Cases
How Are Market Trends Influencing Competition In The Hemoglobinopathies Treatment Market?
Leading businesses in the hemoglobinopathies treatment market are innovating cell-based gene therapies as potential curative treatments for patients with these genetic ailments. These cell-based gene therapies may correct the primary genetic defects in hemoglobinopathies, offering long-lasting or curative effects, diminishing symptoms and complications, and enhancing treatment alternatives for affected individuals. For instance, Vertex Pharmaceuticals Incorporated, an American biotech firm, unveiled Casgevy in December 2023, a treatment for sickle cell disease (SCD) and transfusion-dependent beta thalassemia. Casgevy, a cell-based gene therapy employs CRISPR/Cas9 technology to modify patients’ hematopoietic stem cells, amplifying the production of fetal hemoglobin to thwart the deformation of red blood cells. The therapy entails a one-time process of collecting, modifying, and reinfusing the patient’s stem cells.
Which Firms Are Making The Biggest Impact In The Hemoglobinopathies Treatment Market?
Major companies operating in the hemoglobinopathies treatment market are Pfizer Inc., Sanofi S.A., Novartis AG, Bristol Myers Squibb, Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Pharmacosmos A/S, Alnylam Pharmaceuticals, Global Blood Therapeutics Inc., Acceleron Pharma Inc., Sangamo Therapeutics Inc., Gamida Cell Ltd., Beam Therapeutics, Intellia Therapeutics, Adaptimmune Therapeutics, Orchard Therapeutics plc, Fresenius SE & Co. KGaA, Editas Medicine, Agios Pharmaceuticals Inc., Emmaus Life Sciences Inc., Bluebird Bio Inc., CRISPR Therapeutics AG, Bioverativ Inc., Celgene Corporation, EMI Holding Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/hemoglobinopathies-treatment-global-market-report
Which Region Holds The Greatest Opportunity For Hemoglobinopathies Treatment Market Expansion?
North America was the largest region in the hemoglobinopathies treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobinopathies treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15583&type=smp
Browse Through More Reports Similar to the Global Hemoglobinopathies Treatment Market 2025, By The Business Research Company
Hemoglobin A1C Testing Devices Global Market Report 2025
Hemoglobin Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report
Paroxysmal Nocturnal Hemoglobinuria Pnh Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
